OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry
Laurent Coudeville, Gabriela B. Gomez, Ombeline Jollivet, et al.
Vaccine (2020) Vol. 38, Iss. 48, pp. 7588-7595
Open Access | Times Cited: 17

Showing 17 citing articles:

A mathematical programming approach for equitable COVID-19 vaccine distribution in developing countries
Madjid Tavana, Kannan Govindan, Arash Khalili Nasr, et al.
Annals of Operations Research (2021)
Open Access | Times Cited: 75

Innovations and development of Covid-19 vaccines: A patent review
Ahmed Subeh Alshrari, Shuaibu Abdullahi Hudu, Mohd Imran, et al.
Journal of Infection and Public Health (2021) Vol. 15, Iss. 1, pp. 123-131
Open Access | Times Cited: 44

Public Perceptions of COVID-19 Vaccines: Policy Implications from US Spatiotemporal Sentiment Analytics
G. G. Md. Nawaz Ali, Md. Mokhlesur Rahman, Md. Amjad Hossain, et al.
Healthcare (2021) Vol. 9, Iss. 9, pp. 1110-1110
Open Access | Times Cited: 29

Two-stage approach for COVID-19 vaccine supply chain network under uncertainty using the machine learning algorithms: A case study
Mahdyeh Shiri, Parviz Fattahi, Fatemeh Sogandi
Engineering Applications of Artificial Intelligence (2024) Vol. 135, pp. 108837-108837
Closed Access | Times Cited: 3

Barriers to achieving sustainability in pharmaceutical supply chains in the post-COVID-19 era
Sharmine Akther Liza, Naimur Rahman Chowdhury, Sanjoy Kumar Paul, et al.
International Journal of Emerging Markets (2022) Vol. 18, Iss. 12, pp. 6037-6060
Closed Access | Times Cited: 15

Supply chain risk factor assessment of Indian pharmaceutical industry for performance improvement
Astha Sharma, Dinesh Kumar, Navneet Arora
International Journal of Productivity and Performance Management (2022) Vol. 73, Iss. 1, pp. 119-157
Closed Access | Times Cited: 13

Modeling approaches for early warning and monitoring of pandemic situations as well as decision support
Jonas Botz, Danqi Wang, Nicolas Lambert, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 11

Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study
Laurent Coudeville, Ombeline Jollivet, Cedric Mahé, et al.
PLoS ONE (2021) Vol. 16, Iss. 4, pp. e0250797-e0250797
Open Access | Times Cited: 14

Preparing for the upcoming 2022/23 influenza season: A modelling study of the susceptible population in Australia, France, Germany, Italy, Spain and the United Kingdom
Bronke Boudewijns, John Paget, Marco Del Riccio, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 5

Public Perceptions about COVID-19 Vaccines: Policy Implications from US Spatiotemporal Sentiment Analytics
G. G. Md. Nawaz Ali, Md. Mokhlesur Rahman, Md. Amjad Hossain, et al.
(2021)
Open Access | Times Cited: 6

Public Perceptions about COVID-19 Vaccines: Policy Implications from US Spatiotemporal Sentiment Analytics
G. G. Md. Nawaz Ali, Md. Mokhlesur Rahman, Amjad Hossain, et al.
SSRN Electronic Journal (2021)
Closed Access | Times Cited: 6

COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity
Suhad Daher‐Nashif, Rania Al-Anany, Menatalla Ali, et al.
Archives of Virology (2022) Vol. 167, Iss. 9, pp. 1773-1783
Open Access | Times Cited: 4

A-share Stock Reactions to the Approval of COVID-19 Vaccine Clinical Trial: An Event Study Model of Listed Pharmaceutical Firms’ Returns
Kewei Xiong, Yuanyuan Liang
2020 2nd International Conference on Economic Management and Model Engineering (ICEMME) (2020), pp. 404-407
Closed Access | Times Cited: 3

The impact of the COVID-19 pandemic on the sustainable development of pharmaceutical companies: Evidence from Russia
Irina Pylaeva, Mariya Podshivalova, D. V. Podshivalov
Voprosy Ekonomiki (2022), Iss. 10, pp. 86-112
Closed Access | Times Cited: 1

To Vaccinate or not to Vaccinate; That is the Question! (New Insights into COVID-19 Vaccination)
Sarah El-Nakeep
Current Molecular Medicine (2021) Vol. 22, Iss. 7, pp. 567-571
Closed Access | Times Cited: 1

A Bayesian predictive analytics model for improving long range epidemic forecasting during an infection wave
Pedro Avelar, Natalia del Coco, Luis C. Lamb, et al.
Healthcare Analytics (2022) Vol. 2, pp. 100115-100115
Open Access

Page 1

Scroll to top